Exceptional M&A and Financing Outcomes for Health Sciences Companies
Exceptional Outcomes for Health Sciences Companies
Crosstree Capital is a global leader in health sciences M&A and Financing Advisory. Our vast experience, global C-level professional network, and deep domain expertise result in exceptional outcomes for our clients.
We work with companies involved in global research, development and commercialization of biopharmaceutical, diagnostic and device products; diagnostic services; digital health, and the delivery of health care products and services.
No one is focused on health sciences quite like us.
Our unique industry coverage puts us in the center of the most pivotal themes in healthcare – an evolution to precision medicine, leveraging data to drive better research and clinical utility and balancing cost with outcomes. Crosstree is a dynamic, creative and entrepreneurial team committed to your industry and your success.
Crosstree publishes monthly Industry BlueBooks covering M&A and Financing transactions throughout the globe, in addition to valuations and related segment trends. Keep your pulse on the industry by subscribing to our distribution list.